These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 7023479

  • 1. Impaired negative cooperativity of the semisynthetic analogues human [LeuB24]- and [LeuB25]-insulins.
    Keefer LM, Piron MA, De Meyts P, Gattner HG, Diaconescu C, Saunders D, Brandenburg D.
    Biochem Biophys Res Commun; 1981 Jun 16; 100(3):1229-36. PubMed ID: 7023479
    [No Abstract] [Full Text] [Related]

  • 2. Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin.
    Tager H, Thomas N, Assoian R, Rubenstein A, Saekow M, Olefsky J, Kaiser ET.
    Proc Natl Acad Sci U S A; 1980 Jun 16; 77(6):3181-5. PubMed ID: 6997872
    [Abstract] [Full Text] [Related]

  • 3. [LeuB24]insulin and [AlaB24]insulin: altered structures and cellular processing of B24-substituted insulin analogs.
    Assoian RK, Thomas NE, Kaiser ET, Tager HS.
    Proc Natl Acad Sci U S A; 1982 Sep 16; 79(17):5147-51. PubMed ID: 6752939
    [Abstract] [Full Text] [Related]

  • 4. [LeuB24]- and [LeuB25]insulins are not antagonists of lipogenesis in adipocytes.
    Diaconescu C, Saunders D, Gattner HG, Brandenburg D.
    Hoppe Seylers Z Physiol Chem; 1982 Feb 16; 363(2):187-92. PubMed ID: 7037593
    [Abstract] [Full Text] [Related]

  • 5. Preparation and biological properties of [LeuB24, LeuB25]human insulin.
    Jonczyk A, Keefer LM, Naithani VK, Gattner HG, De Meyts P, Zahn H.
    Hoppe Seylers Z Physiol Chem; 1981 May 16; 362(5):557-61. PubMed ID: 7019034
    [No Abstract] [Full Text] [Related]

  • 6. Characteristics of binding of a low affinity, noncooperative insulin [( LeuB25]insulin) to IM-9 lymphocytes.
    Green A, Frank BH, Rubenstein A, Tager H, Olefsky JM.
    Endocrinology; 1983 Dec 16; 113(6):1963-71. PubMed ID: 6357764
    [Abstract] [Full Text] [Related]

  • 7. Receptor binding and negative cooperativity of a mutant insulin, [LeuA3]-insulin.
    Kobayashi M, Takata Y, Ishibashi O, Sasaoka T, Iwasaki TM, Shigeta Y, Inouye K.
    Biochem Biophys Res Commun; 1986 May 29; 137(1):250-7. PubMed ID: 3521604
    [Abstract] [Full Text] [Related]

  • 8. Semisynthesis and biological properties of the [B24-leucine]-, [B25-leucine[- and [B24-leucine, B25-leucine]-analogues of human insulin.
    Inouye K, Watanabe K, Tochino Y, Kanaya T, Kobayashi M, Shigeta Y.
    Experientia; 1981 May 29; 37(8):811-3. PubMed ID: 7026270
    [Abstract] [Full Text] [Related]

  • 9. Structure-function relationships of shortened [LeuB25]insulins, semisynthetic analogues of a mutant human insulin.
    Fischer WH, Saunders D, Brandenburg D, Diaconescu C, Wollmer A, Dodson G, De Meyts P, Zahn H.
    Biol Chem Hoppe Seyler; 1986 Sep 29; 367(9):999-1006. PubMed ID: 3539147
    [Abstract] [Full Text] [Related]

  • 10. Negative and positive site-site interactions, and their modulation by pH, insulin analogs, and monoclonal antibodies, are preserved in the purified insulin receptor.
    Wang CC, Goldfine ID, Fujita-Yamaguchi Y, Gattner HG, Brandenburg D, De Meyts P.
    Proc Natl Acad Sci U S A; 1988 Nov 29; 85(22):8400-4. PubMed ID: 3054887
    [Abstract] [Full Text] [Related]

  • 11. Mutations at the dimer, hexamer, and receptor-binding surfaces of insulin independently affect insulin-insulin and insulin-receptor interactions.
    Shoelson SE, Lu ZX, Parlautan L, Lynch CS, Weiss MA.
    Biochemistry; 1992 Feb 18; 31(6):1757-67. PubMed ID: 1737029
    [Abstract] [Full Text] [Related]

  • 12. Mapping of the residues responsible for the negative cooperativity of the receptor-binding region of insulin.
    De Meyts P, Van Obberghen E, Roth J.
    Nature; 1978 Jun 15; 273(5663):504-9. PubMed ID: 661960
    [Abstract] [Full Text] [Related]

  • 13. Negative cooperativity: a positive finding?
    Rodbard D.
    Am J Physiol; 1979 Sep 15; 237(3):E203-5. PubMed ID: 474746
    [No Abstract] [Full Text] [Related]

  • 14. Internalization and degradation of a low affinity insulin ([LeuB24]insulin) by rat adipocytes.
    Green A, Tager H, Rubenstein A, Frank B, Olefsky JM.
    FEBS Lett; 1982 Aug 02; 144(2):255-8. PubMed ID: 6749549
    [No Abstract] [Full Text] [Related]

  • 15. Receptor binding and biological activity of [SerB24]-insulin, an abnormal mutant insulin.
    Kobayashi M, Haneda M, Maegawa H, Watanabe N, Takada Y, Shigeta Y, Inouye K.
    Biochem Biophys Res Commun; 1984 Feb 29; 119(1):49-57. PubMed ID: 6367745
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Binding of insulin to bovine liver plasma membrane. Use of insulin analogues modified at the A1 residue.
    Rösen P, Simon M, Reinauer H.
    Biochem J; 1980 Mar 15; 186(3):945-52. PubMed ID: 6994716
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.